Passez à l'illimité avec Magzter GOLD

Passez à l'illimité avec Magzter GOLD

Obtenez un accès illimité à plus de 9 000 magazines, journaux et articles Premium pour seulement

$149.99
 
$74.99/Année

Essayer OR - Gratuit

Indian VCs join the race to back next big AI disruptor

Mint Mumbai

|

February 24, 2025

The world may still be trying to gauge the scale of upheaval from generative AI.

- Rwit Ghosh & Shouvik Das

Indian VCs join the race to back next big AI disruptor

Yet, Indian venture capital investors have joined top global peers in chasing the next disruptive offshoot of generative AI: agentic AI.

Agentic AI is a sophisticated algorithm that can adapt and learn on its own, building on the success of large language models like ChatGPT that need humans to train them. Built for a specific field, it resembles a worker skilled in a certain task—such as customer service, invoicing and more—and operates as a network of skilled professionals to automate tasks.

"Even though the technology is in nascent stages—closer to OpenAI's ChatGPT 3.0—the excitement around agentic systems is about the potential of completely automating repeatable tasks that were taking up a lot of effort," said Prayank Swaroop, partner at Accel, which has started investing in the technology.

Last week, decade-old health-tech firm Innovaccer debuted seven such agents to relieve overworked doctors and medical staff around the world. The San Francisco-based startup is now valued at around $3.5 billion, after raising funds from Facebook co-founder Eduardo Saverin's Singapore-based B Capital Group, and Microsoft's investing arm M12 participate.

Indian venture capital firms are also scouting for potential investment opportunities in some of the world's most promising agentic AI ventures in India and overseas.

PLUS D'HISTOIRES DE Mint Mumbai

Mint Mumbai

Mint Mumbai

Gen Alpha will make new rules for their workplace

Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’

time to read

3 mins

December 01, 2025

Mint Mumbai

EC extends electoral roll revision by a week to II Dec; final list on 14 Feb

The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.

time to read

2 mins

December 01, 2025

Mint Mumbai

THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS

These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.

time to read

3 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

Green hydrogen: Fast fashion could help bump up demand

A boom in its use for clean synthetic inputs might make a difference

time to read

3 mins

December 01, 2025

Mint Mumbai

Let's be a bit more selective in using the word 'reforms'

Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.

time to read

3 mins

December 01, 2025

Mint Mumbai

As mid-cap alpha shrinks, should you consider passive strategies?

Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey

time to read

4 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

With $2.2 bn fund, ChrysCap has appetite for riskier bets

MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing

time to read

3 mins

December 01, 2025

Mint Mumbai

GDP growth of 8% plus: How to sustain this pace

Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships

time to read

2 mins

December 01, 2025

Mint Mumbai

INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES

Detection tools today are not universal or consistent across languages

time to read

5 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

APIs to innovation: Bulk drug makers ramp up CDMO bets

Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.

time to read

2 mins

December 01, 2025

Listen

Translate

Share

-
+

Change font size